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Summary 
 
The standard reference clinical score quantifying average Parkinson’s disease (PD) symptom 
severity is the Unified Parkinson’s Disease Rating Scale (UPDRS). At present, UPDRS is 
determined by the subjective clinical evaluation of the patient’s ability to adequately cope 
with a range of tasks. In this study, we extend recent findings that UPDRS can be objectively 
assessed to clinically useful accuracy using simple, self-administered speech tests, without 
requiring the patient’s physical presence in the clinic. We apply a wide range of known 
speech signal processing algorithms to a large database (~6,000 recordings from 42 PD 
patients, recruited to a six-month, multi-centre trial) and propose a number of novel, 
nonlinear signal processing algorithms which reveal pathological characteristics in PD more 
accurately than existing approaches. Robust feature selection algorithms select the optimal 
subset of these algorithms, which is fed into non-parametric regression and classification 
algorithms, mapping the signal processing algorithm outputs to UPDRS. We demonstrate 
rapid, accurate replication of the UPDRS assessment with clinically useful accuracy (about 2 
UPDRS points difference from the clinicians’ estimates,   0.001). This study supports the 
viability of frequent, remote, cost-effective, objective, accurate UPDRS telemonitoring based 
on self-administered speech tests. This technology could facilitate large-scale clinical trials 
into novel PD treatments. 
 
3 
 
1. Introduction 
 
Parkinson’s disease (PD) is a common neurodegenerative disorder with prevalence rates 
exceeding 100/100,000 (von Campenhausen et al. 2005). Furthermore, it is possible that 
these statistics underestimate the problem, since an additional 20% of people with 
Parkinson’s (PWP) are not diagnosed (Schrag et al. 2002). Given that age is the single most 
important risk factor for PD onset, particularly after age 50 (Elbaz et al. 2002), and the fact 
that the population is growing older, these figures could rise further in the near future.  
PD is believed to be due to substantial dopaminergic neuron reduction in a brain region 
known as the basal ganglia, and its aetiology is unknown (hence it is often referred to as 
idiopathic PD). Parkinsonism exhibits similar PD-like symptoms, but these can be attributed 
to known causes, such as drugs or exposure to neurotoxins. The constellation of PD 
symptoms includes tremor, rigidity and general movement disorders, as well as cognitive 
impairment (Pahwa and Lyons 2007). Speech disorders are amongst the earliest indicators of 
PD onset (Harel et al. 2004), and are reported in about 90% of PWP (Ho et al. 1998); 
moreover 29% of the patients themselves regard speech impairment as one of their most 
troublesome symptoms (Hartelius and Svensson 1994). In addition, there is ample empirical 
evidence for speech degradation as the disease progresses (Harel et al. 2004; Holmes et al. 
2000; Skodda et al. 2009), typically attributed to reduced voice amplitude (hypophonia), and 
increased breathiness (noise) in the PWP’s voice (Ho et al. 1998; Pahwa and Lyons 2007). 
At present, there is no cure for PD, although medication and surgical intervention may 
alleviate some of the symptoms and improve quality of life for most (Singh et al. 2007). 
However, early diagnosis and frequent disease tracking are critical to maximizing the effect 
of treatment (Tolosa et al. 2009; Pahwa and Lyons 2007). PD symptom tracking is currently 
achieved via regular physical visits by the PWP to the clinic, and the subjective assessment of 
the subject’s ability to perform a range of empirical tests as observed by expert clinical raters. 
Nevertheless, despite the clinicians’ experience and the available guidelines, PD symptom 
assessment often varies between experts (inter-rater variability) (Ramaker et al. 2002; Post et 
al. 2005) accentuating the need for an objective clinical tool to track average PD symptom 
progression. 
As part of the clinical assessment, the PWP’s ability to complete the requested empirical 
tasks is mapped to a rating scale specifically designed to follow disease progression. Of the 
various rating scales for monitoring PD progression, the Unified Parkinson’s Disease Rating 
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Scale (UPDRS) is the most widely used for quantifying symptom severity (Ramaker et al. 
2002). For untreated patients the UPDRS comprises a total of 44 sections where each section 
spans the numerical range 0-4 (0 denotes healthy and 4 denotes severe symptoms), and the 
final UPDRS is the summation of all sections (numerical range 0-176, with 0 representing 
perfectly healthy individual and 176 total disability). The UPDRS consists of three 
components: (1) Mentation, behavior and mood (4 sections); (2) Activities of daily living (13 
sections), assessing whether PWP can complete daily tasks unassisted; and (3) Motor (27 
sections), addressing muscular control. We refer to all three components collectively as total 
UPDRS. The third component commonly referred to as motor UPDRS, includes the sections 
18-44 and ranges from 0-108, with 0 indicating no motor symptoms (such as tremor, rigidity, 
posture, stability, bradykinesia) and 108 denoting total lack of motor control. Speech appears 
explicitly in two sections: once in section 5 (understandable speech – part of the second 
UPDRS component) and once in section 18 (expressive speech – part of the third UPDRS 
component), and ranges between 0-8 with 8 being unintelligible. The medical rater assesses 
the subject’s speech performance (quantifying how understandable and expressive speech is) 
during casual discussion. Figure 1 presents succinctly the details of the UPDRS metric. 
Telemonitoring-based health care is an emerging field combining medical care and 
Internet-enabled technology. On the one hand, it facilitates fast, frequent, remote tracking of 
disease progression, minimizing the need for regular and inconvenient visits to the clinic. On 
the other hand, it significantly alleviates the burden on national health systems of excessive 
workload and the large, associated costs of clinical human expertise. Recently, Intel 
Corporation’s novel telemonitoring system, known as the At-Home Testing Device (AHTD), 
was developed (Goetz et al. 2009). This device facilitates remote, non-invasive self-
administered tests, which are specifically designed to track PD progression and include 
manual dexterity and speech tests. The speech tests consist of running speech and sustained 
vowel phonations; in this study we concentrate on the latter. The use of sustained vowels, 
where the subject is requested to hold the frequency of phonation steady for as long as 
possible, builds on empirical evidence that healthy subjects can elicit steady phonation, 
whereas subjects with some form of vocal impairment cannot (Titze 2000). The use of 
sustained vowels to assess the extent of vocal symptoms avoids some of the known 
confounding effects of articulatory movement in running speech (Schoentgen and De 
Gucteneere 1995), and is therefore common in general speech clinical practice (Titze 2000). 
Previous studies used speech signals aiming to separate PWP from healthy controls (Harel 
et al. 2004; Little et al. 2009), and in the past year some authors highlighted the importance 
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of exploring the topic of mapping speech signals to UPDRS (Skodda et al. 2009; Goetz et al. 
2009) in future studies. Motivated by these studies, we have recently used a number of well 
known speech signal processing algorithms which are traditionally used by clinical speech 
scientists to characterize dysphonias (malfunctions in voice production) and demonstrated the 
feasibility of using statistical machine learning techniques to map the results of these 
algorithms (features) to motor-UPDRS and total-UPDRS (Tsanas et al. 2010a; Tsanas et al. 
2010b).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Overview of the clinical metric that quantifies average Parkinson’s disease symptom 
severity, the Unified Parkinson’s Disease Rating Scale (UPDRS). Speech appears explicitly twice. 
 
In this study, we expand our analysis to introduce and investigate a range of speech signal 
processing algorithms which have not previously been used to characterize PD voices. 
Moreover, we present some novel nonlinear speech signal processing measures, which 
uncover many useful properties and characteristic patterns of PD dysphonia, that to-date, 
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remained concealed due to limitations of existing speech signal processing algorithms. In 
addition, we show that splitting the data into male and female data subsets (data partitioning) 
reveals distinct speech PD progression characteristics in males and females and this 
tentatively suggests different pathological patterns in these two groups. We demonstrate that 
we can replicate the clinicians’ UPDRS estimates to within 2 points, that is, with greater 
accuracy than the inter-rater variability (4-5 UPDRS points) (Post et al. 2005). These new 
findings significantly improve on previous studies which introduced the concept of using 
speech signals to replicate the clinicians’ UPDRS assessment, where the reported UPDRS 
accuracy was within 7.5 points. 
This proposed objective machine learning framework using speech signals offers a 
promising approach to automating subjective UPDRS tracking, which would otherwise 
require the dedicated time of a clinical rater. This innovative approach is less cumbersome for 
patients since it reduces the need for frequent physical visits to the clinic. It is therefore also 
cost-effective for national health systems, and replicates the clinicians’ estimates very 
accurately. We envisage this method being used to regularly and remotely track PD symptom 
progression by UPDRS, and facilitating large scale clinical trials into novel PD treatments. 
Lastly, the proposed signal processing features could be useful in affiliated research fields 
that use acoustic analysis of speech signals to assess various voice production pathologies. 
 
  
2. Data 
 
We use data collected in the study of Goetz et al. (2009), recently summarized in Tsanas et al. 
(2010a). In short, 52 subjects diagnosed with idiopathic PD within the previous five years at 
the time of a baseline clinical visit, were recruited into a trial of the AHTD. All subjects gave 
written informed consent, remained un-medicated for the six-month duration of the study and 
were asked to complete a range of tests weekly. Subjects were diagnosed with PD if they had 
at least two of the following symptoms: rest tremor, bradykinesia (slow movement), or 
rigidity, without evidence of other forms of Parkinsonism. No exclusion criteria related to 
specific PD symptoms (e.g. depression) were used. We disregarded data from 10 recruits – 
two that dropped out the study early, and a further eight that did not complete at least 20 valid 
study sessions during the trial period. Thus, this study concentrates on 42 PWP, and their 
details are summarized in Table 1. 
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Table 1: Summary of the AHTD data for the recruited male and female subjects. 
 MALES (28 subjects) FEMALES (14 subjects) 
Age 
(years) 
Mean ± standard deviation: 64.8 ± 
8.1, min. 49, max. 78, median 65 
Mean ± standard deviation: 63.6 ± 
11.6, min. 36, max. 85, median 64 
Weeks since PD 
diagnosis 
Mean ± standard deviation: 63.0 ± 
61.9, min. 1, max. 260, median 48  
Mean ± standard deviation: 89.7 ± 
81.2, min. 4, max. 252, median 60 
Motor-UPDRS 
(baseline, 
3-months, 
6-months) 
Mean ± standard deviation: (20.3 ± 
8.5, 21.9 ± 8.7, 22.0 ± 9.2), min. (6, 
6, 5), max. (36, 38, 41), median (21, 
22, 20)  
Mean ± standard deviation: (17.6 ± 
7.4, 21.2 ± 10.5, 20.1 ± 9.4), min. 
(6, 6, 8), max. (32, 38, 38), median 
(18, 18.5, 19.5) 
Total-UPDRS 
(baseline, 
3-months, 
6-months) 
Mean ± standard deviation: (27.5 ± 
11.6, 30.4 ± 11.8, 31.0 ± 12.4), min. 
(8, 7, 7), max. (54, 55, 54), median 
(27, 28.5, 26.5) 
Mean ± standard deviation: (24.2 ± 
9.1, 27.4 ± 12.1, 26.8 ± 10.8), min. 
(10, 7, 10), max. (42, 46, 49), 
median (25, 28, 24.5) 
 
 
Table 2: Specifications of the At-Home Testing Device (AHTD) speech data collection interface. 
AHTD instructions 
Audible prompts prior to each test; visual prompts on the liquid 
crystal display, additional detailed help (text) available if needed 
Microphone 
High quality head-mounted, placed 5 cm from the subject’s lips, 
Polarity: cardioid, typical dynamic range: 96 dB, 1 kHz at 
maximum sound pressure level, signal to noise ratio 58 dB, 1 kHz 
at 1 Pa, Frequency response: 100-13,000 Hz, Low frequency roll-
off: 80 Hz, 18 dB/octave 
Analogue-to-digital 
conversion 
24 kHz at 16 bits resolution 
Storage Data recorded directly onto the AHTD USB data stick 
Recording conditions Subjects are required to be in a quiet place at home 
Transmission Data encrypted, transmitted over the internet to dedicated server 
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Figure 2 Schematic diagram of the steps from the data acquisition up to UPDRS estimation. The 
device that collects the data from the Parkinson’s disease (PD) patient is known as the At-Home-
Testing-Device (AHTD). The red box (steps 6-8) is the focus of this study. 
 
A schematic diagram of the speech data acquisition process using the AHTD and the 
UPDRS estimation is presented in figure 2, and specifications of equipment are summarized 
in Table 2. The subjects in the study successfully completed a period of training in usage of 
the AHTD and used the device at their homes to self-collect the data. On each day the test 
was performed, the AHTD recorded six phonations: four at comfortable pitch and loudness 
and two at twice the initial loudness (but without shouting). The AHTD uses audible and 
visual prompts instructing the user to undertake specific tasks, including how to wear the 
head-mounted headset and the use of twice the initial loudness in the two final phonations. 
Although this latter aspect was not explicitly quantified, it has been empirically found that 
 Parkinson’s  
disease patient 
speaks into 
microphone 
 Home 
telemonitoring 
device records  
speech signal 
 Speech 
transferred 
to USB stick 
 
Internet 
Patient’s home Medical Centre 
 Data into 
 patient’s 
 personal 
 computer 
 Dysphonia 
measures 
applied to  
speech 
 Statistical 
mapping of 
algorithms to 
UPDRS 
 Predicted 
UPDRS report 
to clinical staff 
 Data into 
dedicated 
server in the  
clinic 
 
0 0.5 1
0
10
20
PPE
UP
D
R
S
 
 
J=|F0,i-F0,i+1| 
 
9 
 
paying conscious attention to speech articulation results in vocal performance improvement 
(Ho et al. 1999). Further details of the AHTD trial can be found in Goetz et al. (2009). 
After initial screening to remove flawed phonations (too short, patient coughing, failure to 
capture phonation onset), we processed 5,875 sustained vowel “ahh…” signals. All signal 
processing and machine learning algorithms were implemented in the Matlab software 
package. 
 
3. Methods 
 
The methodology of this study can be succinctly described in three steps: 1) extracting 
features characterizing the underlying patterns of the speech signals using signal processing 
algorithms (feature extraction), 2) selecting a parsimonious subset of these features 
comprising relevant and minimally overlapping information with regard to UPDRS 
prediction (feature selection), and 3) mapping the feature subset to UPDRS using 
classification and regression methods (statistical mapping) in a standard supervised learning 
setup. Ultimately, we want to use the speech signals to replicate the clinicians’ UPDRS 
assessment. In doing this, we tacitly assume that voice degradation is attributed solely to PD. 
It is conceivable that vocal performance could have been affected by confounding factors (for 
example emotional state) or pathological conditions (for example a disorder of voice 
production not related to PD). However, it is highly unlikely that these confounding factors 
affect more than a small minority of the AHTD subjects, thus contaminating only a few of the 
available recordings. Another source of error might be equipment tolerance. However, the 
speech data acquisition equipment is more than sufficient for the requirements of reliable 
speech signal processing (for details of the minimum requirements see (Titze 2000)), and 
thorough tests before the AHTD trial data acquisition process verified that the high-quality 
equipment used in the device lead to accurate recordings. 
 
3.1 Feature extraction 
 
The duration between two successive openings (or closures) of the vocal folds defines a 
vocal fold cycle (or simply cycle), where the vocal fold oscillation pattern (vocal fold 
opening and closure) is typically considered nearly periodic in healthy voices. That is, the 
intervals of time where the vocal folds are apart or in collision remain almost equal between 
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successive cycles. Speech scientists typically refer to those oscillation intervals as pitch 
period or fundamental frequency  (reciprocal of pitch period – see figure 3). Whereas in 
healthy voices the vocal folds collide and remain together for a fixed portion of the cycle, in 
voice pathologies this pattern may be severely affected. In addition, a common manifestation 
of vocal impairment is incomplete vocal fold closure, resulting in excessive breathiness 
(noise). This imbalanced vocal fold movement also results in turbulent noise and the 
appearance of vortices in the airflow from the lungs, increasing the energy at higher energy 
components (Godino-Llorente et al. 2006). In general, people with voice disorders cannot 
elicit steady phonations (Titze 2000), and speech signal processing algorithms attempt to 
quantify this inefficiency at converting steady airflow from the lungs into stable voice. 
 
 
Fig. 3 (a) Typical sustained vowel phonation signal. (b) The same signal magnified in the time axis. 
The horizontal axes are time in seconds and the vertical axes amplitude (no units). Clear overall 
amplitude decay over the duration of the phonation can be seen in panel (a). A careful look at the 
magnified signal (b) reveals that it is not exactly periodic, a characteristic that many dysphonia 
measures aim to address. 
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The aim is to analyse the digitized acoustic signal using signal processing algorithms that 
take into account the pathophysiological implications outlined above, so that useful clinical 
information can be extracted. These algorithms are collectively known as dysphonia 
measures in the speech literature. Each of those measures is applied to each of the 5,875 
recordings used in the study, resulting in a scalar value or a vector with a few entries per 
recording. Many algorithms work on time windows (small portions of the original speech 
signal). The output of those algorithms is then typically the average or some form of 
normalized average of the computed values on each of the time windows.  
Previously, we had used the freely available Praat software package (Boersma and 
Weenink 2009) to extract 13 commonly-used measures (Tsanas et al. 2010a; Tsanas et al. 
2010b) and three new measures we had proposed recently (Little et al. 2007; Little et al. 
2009). In this study, all algorithms were implemented in Matlab using the equations described 
in the Electronic Supplementary Material (Section 1). In addition to the classical dysphonia 
measures, we introduce a range of novel nonlinear measures which we demonstrate convey 
important additional information useful in replicating the clinicians’ UPDRS estimates. The 
outputs of the signal processing algorithms are concatenated into a feature vector which 
characterizes each of the 5,875 phonations. 
 
3.2 Data exploration and statistical analysis 
 
The UPDRS values of this study were obtained at baseline, three-month and six-month times 
in the trial, but the voice recordings were obtained weekly; therefore we need to obtain 
weekly UPDRS values to associate with each phonation. There is strong empirical evidence 
that average PD symptom progression in the early stages of the disease (up to about five 
years) is almost linear in non-medicated patients as observed in clinical metrics (Schüpbach 
et al. 2010; Maetzler et al. 2009). Therefore, given that the AHTD study recruits were in the 
early PD stages and remained non-medicated, a straightforward piecewise linear interpolation 
going exactly through the measured baseline, three-month and six-month motor-UPDRS and 
total-UPDRS scores is the most parsimonious and sensible approach to derive weekly values 
(Tsanas et al. 2010a; Tsanas et al. 2010b). The tacit assumption is that symptom severity did 
not fluctuate wildly within the three-month intervals in between which the UPDRS scores 
were obtained.  
Correlation coefficients are the first quantities we explored in attempting to assess the 
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strength of association of the dysphonia measures with the linearly interpolated UPDRS 
values. The data was non-normal, so we used the non-parametric Spearman correlation 
coefficient. We also computed p-values (at the 95% level) of the null hypothesis against each 
dysphonia measure being uncorrelated with motor-UPDRS and total-UPDRS. In addition, we 
calculated the Spearman correlation coefficients between different dysphonia measures to 
assess the extent to which they contain overlapping information. We have also used the 
mutual information (MI) 	
, , where ,  are random variables (Cover and Thomas 2006), 
as a more inclusive, robust estimator of the association strength between the measures and 
UPDRS. The mutual information is non-negative, and is not upper bounded; therefore for 
ease of comparison we normalized 	
,  by dividing it through with 	
, : hence, the 
reported mutual information in this study lies in the range zero (no dependence between , ) 
to one ( determines  completely). Both the correlation coefficients and the mutual 
information are used to express the association strength (relevance) of each measure with 
UPDRS. 
 
3.3 Feature selection 
 
A ubiquitous problem in data analysis is the curse of dimensionality: the presence of a large 
number of features occludes the elucidation of useful patterns underlying the data, and is 
often detrimental in the subsequent learning process (see Section 3.4). This occurs because 
the required samples to adequately populate the feature space grow exponentially with the 
number of features, and typically is considerably more than the available data. Following the 
general principle of parsimony, which simply means that given several models with equal 
predictive power, we should prefer the model that uses the least number of features, it is 
desirable to reduce the number of features (hence produce a sparse model) in the analysis and 
still obtain an accurate estimate of the UPDRS. Selecting a subset of features may or may not 
improve the model’s prediction accuracy; however it always enhances the model’s 
interpretability. This is because we can infer the predominant characteristics of the dataset 
from the properties (latent factors) that the selected features represent, and a small number of 
features promote understanding of the causal relationship between those properties and 
UPDRS. 
Searching through all possible combinations of features is unfeasible because it is 
computationally intractable in principle, giving rise to the need for computationally efficient 
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feature selection algorithms. We have used two generic, powerful feature selection methods: 
the least absolute shrinkage and selection operator (LASSO) (Tibshirani 1996), and a 
popular LASSO extension, the elastic net (Zou and Hastie 2005). Details of these algorithms 
and their promising sparsity-promoting properties can be found in (Tibshirani 1996; Zou and 
Hastie 2005; Hastie et al. 2009). For both algorithms we computed the entire regularization 
solution paths (Hastie et al. 2009). 
 
3.4 Regression and classification: mapping dysphonia measures to UPDRS 
 
The analysis in Section 3.2 provides preliminary indication of the association strength of each 
measure with UPDRS. However, the ultimate aim of this study is to combine the dysphonia 
measures to predict motor-UPDRS and total-UPDRS so that the absolute difference between 
the estimated and the linearly interpolated UPDRS is minimized. That is, we need to form a 
functional relationship 
   which maps the dysphonia measures   
1…M, where 
M is the number of input variables, to the UPDRS output y. This is the classical supervised 
learning setup, which for the problem in question can be tackled using either regression or 
classification mapping techniques. Following the linear interpolation described earlier, the 
UPDRS spans the range of positive real values, i.e.   , which is what we use as the 
mapped quantity (also known as outcome measurement or response variable) in the 
regression scheme. For the classification schemes we used the rounded  scores and treat 
each integer UPDRS value as a different class. 
Previous studies have shown the limitations of classical linear regression methods in this 
application (Tsanas et al. 2010a; Tsanas et al. 2010b), indicating that nonlinear methods may 
be more appropriate. In particular, we have experimented with Classification and Regression 
Trees (CART), and Random Forests (RF). Both CART and RF were tested working in both 
regression and classification modes.  
CART was the method of choice in Tsanas et al. (2010a) because it has been described as 
the best off-the-shelf mapping algorithm in supervised learning contexts (Hastie et al. 2009). 
It partitions the feature space into hyper-rectangles, assigning a value to each of the hyper-
rectangles that is as close as possible in value to the response variable in that region of the 
feature space (typically the mean or the median of the response values in that hyper-
rectangle). This can be viewed as a tree growing process, where each partition splits in two 
branches. To avoid overfitting, i.e. capturing noisy fluctuations in the data at the expense of 
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the underlying structure of the mapping, an internal pruning level parameter is used to 
remove excessive detail in the partitioning of the feature space. The optimal pruning level 
value is typically determined by cross-validation. For further details on the advantages of the 
method and its mathematical foundations, we refer to Hastie et al. (2009). 
A natural extension of CART is random forests (RF), a method comprising of many de-
correlated trees, and can be thought of as ensemble learning, that is, integrating the ‘opinion’ 
of many weaker individual learners (Breiman 2001). The procedure is essentially the same as 
CART regarding the training of the trees (hyper-rectangle feature space partition described 
above); the only difference is that a random subset of the input features is chosen for each 
tree. The tree-growing process is the same as in CART, and there is no pruning; the prediction 
result of the RF learner is an average of the prediction from each tree. Breiman convincingly 
demonstrated that random forests are effective in various prediction tasks, whilst they do not 
overfit as more trees are added to the RF (Breiman 2001). For more information on RF we 
refer the reader to Hastie et al. (2009). 
It is possible that partitioning the data may provide improved classification and regression 
accuracy in statistical machine learning applications. We partitioned the PWP according to 
gender, to investigate whether PD progression can be captured more accurately. That is, 
instead of building a 5,875×M  matrix of feature vectors with all the data (design matrix), we 
used a design matrix of size 4,010×M for male and 1,865×M for female PWP. These design 
matrices contained no invalid or missing entries. Prior to feature selection, we have 132 
dysphonia measures (i.e. initially, M = 132). 
 
3.5 Cross validation and model generalization 
 
We used 10-fold cross-validation to test the generalization performance of the learners used 
in this study. This represents our best estimate of UPDRS estimation performance on what 
we might expect on a new dataset, assuming the new dataset has similar characteristics to the 
AHTD data. Specifically, the initial dataset consisting of N (4,010 for males and 1,865 for 
females) phonations was split into a training subset of 0.9 ·  (3,609 and 1,679) phonations 
and a testing (out of sample) subset of 0.1 ·  (401 and 186) phonations. We repeated the 
process a total of 100 times, randomly permuting the data before splitting into training and 
testing subsets. Similar to our previous work (Tsanas et al. 2010a; Tsanas et al. 2010b), we 
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compared model performance on the basis of mean absolute error (MAE) for each of the 100 
runs for the training and testing subsets: 
   1 |!" # "|"$%  (1) 
where !"  is the predicted UPDRS and "  is the actual UPDRS for the ith entry in the training 
or testing subset, N is the number of phonations in the training or testing subset, and Q 
contains the indices of that set. Errors over the 100 cross-validation realisations were 
averaged. 
 
 
4. Results 
 
4.1  Data exploration 
 
We began the exploration of the data by computing the relevance of speech features to 
UPDRS. Speech appears explicitly in two sections of the UPDRS, which can be combined to 
form the ‘speech-UPDRS’ quantity. Then, the relationships between speech-UPDRS and 
motor-UPDRS are (p < 0.001), Spearman R = 0.464, MI = 0.153 for males, and (p < 0.05), 
Spearman R = 0.323, MI = 0.199 for females. Similarly, the relationships between speech-
UPDRS and total-UPDRS are (p < 0.001), Spearman R = 0.552, MI = 0.22 for males, and (p 
< 0.05), Spearman R = 0.323, MI = 0.168 for females. These preliminary statistical results 
offer good indication that speech and UPDRS are actually linked. Table 3 summarizes the 
dysphonia measures with the largest relevance to UPDRS for male PWP; similarly Table 4 
for female PWP. All measures were significantly correlated (p < 0.001) with linearly 
interpolated motor-UPDRS and total-UPDRS, and some of these measures are quite strongly 
associated with UPDRS, particularly for the female PWP. In addition, figure 4 presents 
scatter plots of the most highly correlated dysphonia measures against UPDRS, giving a 
visual impression of the distribution of the dysphonia signal processing values and their 
relationship to UPDRS. 
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Fig. 4. Scatter plots of the most relevant dysphonia measures against motor UPDRS and total UPDRS 
for males and for females, using the measures presented in Tables 3 and 4. The horizontal axes are the 
normalized dysphonia measures and the vertical axes correspond to UPDRS. The gray lines are the 
best linear fit obtained using Iteratively Reweighted Least Squares – see (Tsanas et al. 2010) for 
details. 
 
We can see that most of the times, large absolute correlation coefficient values correspond 
to large normalized MI values in Tables 3 and 4. However, some dysphonia measures have 
low absolute correlation coefficients and relatively large normalized MI (for example the 7th 
MFCC coefficient in Table 3). This indicates that those dysphonia measures are associated 
with UPDRS in a nonlinear non-monotonic way, which needs to be characterised using higher 
order moments (the Spearman correlation coefficient fails to quantify these relationships). 
Conversely, given two dysphonia measures (for example the VFER-NSRTKEO and the 8th 
delta MFCC coefficient in Table 3), a higher absolute value correlation coefficient might 
correspond to a lower normalized MI. This indicates that the extent of the association 
strength between the 8th delta MFCC coefficient and UPDRS can be adequately quantified 
using a monotonic relationship, whereas the extent of the association strength between the 
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VFER-NSRTKEO and UPDRS relies more on higher order moments. 
 
Table 3: Maximum relevance and correlations of dysphonia measures with UPDRS for males. 
Measure Description 
Motor-UPDRS  
relevance and correlation 
        MI          Spearman R 
Total-UPDRS  
relevance and correlation 
        MI          Spearman R 
VFER-NSRTKEO 
Ratio of the sum of the log-transformed mean 
TKEO of the band-pass signals for frequencies 
>2.5 kHz to the sum of the mean TKEO of the 
band-pass signals for frequencies <2.5 kHz 
0.105 0.159 0.132 0.187 
DFA 
Characterizes the extent of turbulent noise, 
quantifying its stochastic self-similarity (Little 
et al. 2007) 
0.078 -0.162 0.115 -0.205 
7th MFCC coef 7
th
 Mel Frequency Cepstral Coefficient 
(Brookes 2006) 0.079 -0.066 0.108 0.0070 
6th MFCC coef 6
th
 Mel Frequency Cepstral Coefficient 
(Brookes 2006) 0.106 -0.277 0.102 -0.294 
,&'( #
,)*+),-).  
Mean difference of the cycle-to-cycle 
 estimate (extracted using Sun’s algorithm) 
and the average expected   in age- and sex- 
matched healthy controls 
0.088 0.097 0.101 0.018 
Log energy Estimate of the logarithmic energy (Brookes 2006) 0.090 0.149 0.099 0.169 
4th MFCC coef 4
th
 Mel Frequency Cepstral Coefficient 
(Brookes 2006) 0.088 -0.082 0.098 -0.061 
0th MFCC coef 0
th
 Mel Frequency Cepstral Coefficient 
(Brookes 2006) 0.079 0.171 0.099 0.197 
8th MFCC coef 8
th
 Mel Frequency Cepstral Coefficient 
(Brookes 2006) 0.106 0.276 0.095 0.259 
8th delta MFCC 
coef 
8th delta Mel Frequency Cepstral Coefficient 
(First derivative of 8th MFCC) (Brookes 2006) 0.073 0.181 0.093 0.205 
The ranking was determined by the mutual information (MI) with the total UPDRS (for clarity, only the 10 most relevant 
measures are presented here). Relevance denotes the association strength of each feature with UPDRS expressed using the 
MI. The reported MI is normalized (i.e. MI lies between 0-1, where 0 denotes that UPDRS is independent on the dysphonia 
measure, and 1 indicates that UPDRS is completely determined by the dysphonia measure - see Section 3.2 for details). All 
results were rounded to the nearest third decimal digit. The UPDRS relevance and correlation columns are  the MI where the 
probability density functions were computed with kernel density estimation with Gaussian kernels, and the Spearman non-
parametric correlation coefficients between each measure and piecewise linearly interpolated motor and total UPDRS. All 
measures were statistically significantly correlated (p < 0.001) with motor-UPDRS and total-UPDRS. All speech signals 
from the male PWP were used to generate these results (N = 4,010 phonations). The  subscript text refersto the algorithm 
used to extract it. 
 
The overall impression we take from Tables 3 and 4 is that the most highly associated 
dysphonia measures with UPDRS are some of the MFCCs in males, and -related measures 
for females. Specific MFCCs coefficients do not have particular physical meaning, but a 
more general interpretation is possible: lower MFCCs reflect the amplitude and envelope 
spectral fluctuations, and higher MFCCs convey mostly information about harmonic 
components (see the Electronic Supplementary Material for more information on MFCCs). 
The MFCCs in Table 3 are in the mid-range, and they are not easily interpretable since they 
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fall in neither category. We defer elaboration of the -related measures for females for the 
Discussion. 
 
 
Table 4: Maximum relevance and correlations of dysphonia measures with UPDRS for females. 
Measure Description 
Motor-UPDRS  
relevance and correlation 
        MI          Spearman R 
Total-UPDRS  
relevance and correlation 
        MI          Spearman R 
Std ,/"*-'0) Standard deviation of the extracted  ,/"*-'0) 0.205 0.475 0.216 0.470 
Std ,12+- Standard deviation of the extracted  ,12+- 0.174 0.437 0.195 0.434 
GQclosed Standard deviation of the duration that the vocal folds remain closed 0.211 0.236 0.195 0.250 
0th MFCC coef 0
th
 delta Mel Frequency Cepstral Coefficient 
(Brookes 2006) 0.200 -0.327 0.187 -0.344 
,3022-
# ,)*+),-). 
Mean difference of the cycle-to-cycle  
estimate (extracted using Praat’s algorithm) 
and the average expected   in age- and sex- 
matched healthy controls 
0.198 0.103 0.176 0.034 
1st MFCC coef 1
st
 delta Mel Frequency Cepstral Coefficient 
(Brookes 2006) 0.135 -0.047 0.170 -0.031 
Log energy Estimate of the logarithmic energy (Brookes 2006) 0.179 -0.458 0.170 -0.487 
,/"*-'0)
# ,)*+),-).   
Mean difference of the cycle-to-cycle 
estimate (extracted using the mixture 
algorithm) and the average expected   in age- 
and sex- matched healthy controls 
0.181 0.019 0.164 -0.055 
,12+-
# ,)*+),-). 
Mean difference of the cycle-to-cycle  
estimate (extracted using Rapt’s algorithm) and 
the average expected   in age- and sex- 
matched healthy controls 
0.173 0.022 0.158 -0.054 
4
+0,5 5th percentile of the TKEO of the fundamental 
frequency values, obtained with the mixture 
algorithm 
0.177 -0.411 0.153 -0.369 
The ranking was determined by the mutual information (MI) with the total UPDRS (for clarity, only the 10 most relevant 
measures are presented here). Relevance denotes the association strength of each feature with UPDRS expressed using the 
MI. The reported MI is normalized (i.e. lies between 0-1, where 0 denotes that UPDRS is independent of the dysphonia 
measure, and 1 indicates that the UPDRS is completely determined by the measure - see Section 3.2 for details). All results 
were rounded to the nearest third decimal digit. The UPDRS relevance and correlation columns are  the MI where the 
probability density functions were computed with kernel density estimation with Gaussian kernels, and the Spearman non-
parametric correlation coefficients between each measure and piecewise linearly interpolated motor and total UPDRS. All 
measures were statistically significantly correlated (p < 0.001) with motor-UPDRS and total-UPDRS. All speech signals 
from the female PWP were used to generate these results (N = 1,875 phonations). The  subscript text refers to the 
algorithm used to extract it. 
 
4.2  Feature selection and statistical mapping of features to UPDRS 
 
As described in Section 3.3, the LASSO and the elastic net can be used to determine the 
dysphonia measures that may be optimally included in a learner for UPDRS prediction. The 
feature selection process in this report used 10-fold cross validation (we experimented with 
100 runs), where we recorded the selected features across all runs. The sparsity pattern of 
both the LASSO and the elastic net was very stable for the first 10 (and quite stable for the 
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first 15) selected features across the 100 realisations of the 10-fold cross validation. That is, 
the order of the initially selected features was almost the same across each cross-validation 
realisation used in feature selection. In Section 2.1 of the Electronic Supplementary Material 
we compare the 15 most important features selected by the two algorithms. 
 
Table 5: Selected dysphonia measure subsets for males and females 
MALES (33 dysphonia measures) FEMALES (33 dysphonia measures) 
Dysphonia measure 
Motor UPDRS 
MI        R 
Total UPDRS 
MI        R 
Dysphonia measure 
Motor UPDRS 
MI        R 
Total UPDRS 
MI        R 
6th MFCC coef 0.106 -0.277 0.102 -0.294 Log energy 0.179 -0.458 0.170 -0.487 
8th MFCC coef 0.106 0.276 0.095 0.259 Std ,12+- 0.205 0.475 0.216 0.470 
VFERSNR,TKEO 0.077 -0.076 0.077 -0.108 10th MFCC coef 0.112 0.239 0.107 0.250 
VFERmean 0.076 0.154 0.089 0.13 PPE 0.118 0.436 0.105 0.396 
8th delta MFCC 0.073 0.181 0.093 0.205 12th MFCC coef 0.094 0.204 0.088 0.261 
12th delta MFCC 0.048 0.172 0.054 0.167 IMFSNR,TKEO 0.075 -0.127 0.067 -0.067 
0th MFCC coef 0.079 0.171 0.097 0.197 8th MFCC coef 0.114 -0.341 0.092 -0.255 
2nd MFCC coef 0.082 -0.149 0.084 -0.182 11th MFCC coef 0.078 0.127 0.100 0.187 
3rd MFCC coef 0.071 0.091 0.077 0.067 IMFNSR,SEO 0.099 -0.117 0.065 -0.058 
2nd delta MFCC 0.047 0.130 0.050 0.125 GNEmean 0.090 0.035 0.086 -0.062 
3rd delta MFCC 0.046 0.169 0.054 0.161 3rd delta MFCC 0.070 0.149 0.064 0.119 
Std ,&'( 0.046 0.144 0.050 0.129 HNRstd 0.072 0.224 0.066 0.195 
9th MFCC coef 0.075 -0.194 0.073 -0.153 5th MFCC coef 0.113 0.173 0.115 0.188 
7th MFCC coef 0.079 -0.066 0.108 0.007 2nd delta MFCC 0.055 0.172 0.056 0.206 
4th delta MFCC 0.041 0.001 0.044 0.007 GNESNR,TKEO 0.036 0.038 0.042 0.033 
GNESNR,TKEO 0.023 0.074 0.024 0.089 10th delta MFCC 0.071 -0.064 0.066 -0.079 
ShimmerA0,abs 0.042 -0.079 0.058 -0.135 GQopen 0.061 0.256 0.057 0.248 
4
65-7 +)0,)(-"8)  0.074 -0.136 0.078 -0.056 GQclosed 0.211 0.236 0.194 0.25 
IMFSNR,TKEO 0.045 -0.122 0.054 -0.151 4th MFCC coef 0.19 0.329 0.140 0.242 
ShimmerPQ1,K=5 0.041 -0.065 0.056 -0.113 4
95-7 +)0,)(-"8) 0.162 0.413 0.137 0.361 
ShimmerPQ3,K=11 0.043 -0.071 0.057 -0.116 OQ5-95 percentile 0.005 -0.216 0.001 -0.231 
11th MFCC coef 0.081 -0.006 0.070 0.021 6th delta MFCC 0.073 0.152 0.066 0.086 
Jitter-,2:; 0.061 0.103 0.064 0.045 Std ,3022- 0.146 0.352 0.132 0.316 
ShimmerdB 0.040 -0.066 0.054 -0.113 DFA 0.115 -0.059 0.094 -0.023 
GNENSR,TKEO 0.035 0.098 0.033 0.11 VFERSNR,SEO 0.130 -0.253 0.084 -0.175 
RPDE 0.040 0.003 0.044 0.064 Std  4
 0.170 0.325 0.152 0.269 
5th MFCC coef 0.082 0.010 0.081 -0.039 VFERSNR,TKEO 0.085 -0.143 0.086 -0.112 
HNRstd 0.068 0.058 0.086 0.134 5th delta MFCC  0.052 0.075 0.059 0.073 
Jitterpitch period% 0.048 0.070 0.052 0.039 7th MFCC coef 0.086 0.036 0.077 0.044 
13th delta MFCC 0.038 0.114 0.043 0.134 9th MFCC coef 0.084 0.157 0.073 0.147 
DFA 0.078 -0.162 0.112 -0.205 3rd MFCC coef 0.151 -0.132 0.117 -0.058 
VFERNSR,TKEO 0.105 0.159 0.132 0.187 6th MFCC coef 0.169 0.137 0.145 0.084 
12th delta-delta 
MFCC 0.035 0.066 0.049 0.058 4
<5-7 +)0,)(-"8)  0.078 0.067 0.072 0.089 
The order of the features in the subsets is the order with which they were selected in the LASSO algorithm (features that 
were initially selected and subsequently dropped in the LASSO path are not included). The selected feature subsets were 
determined using the one standard error rule (see text for details). The Table also presents the mutual information (MI) and 
Spearman R (relevance and correlation) of the selected features with respect to the motor-UPDRS and total-UPDRS. The 
reported MI is normalized (i.e. MI lies between 0-1, where 0 denotes that UPDRS is independent on the dysphonia measure, 
and 1 indicates that the UPDRS is completely determined by the dysphonia measure - see Section 3.2 for details). 
Descriptions of the dysphonia measures appear in Section 1 of the Electronic Supplementary Material. 
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Then, we used one feature subset at a time (experimenting with the feature subsets 
selected by the LASSO or the elastic net) as input to the CART and RF learners to train and 
test each of the four learners’ performance. Additionally, all the dysphonia measures were 
used as inputs into the learners in order to have a (potentially over-complex) MAE 
benchmark against which we could compare our findings. The pruning level of the CART 
learners was determined by manual checks to minimize the MAE. By default, we used 500 
trees in the RF learners.  
In order to select the best feature subset, we have used the “one-standard-error” rule 
(Hastie et al. 2009): we pick the most parsimonious subset in which the MAE is no more than 
one standard deviation above the MAE of the best subset. The selected feature subsets for 
males and females are summarized in Table 5. In all cases, the RF working in classification 
mode outperformed the other learners. Table 6 presents the out-of-sample MAE using the RF 
learner in classification mode for the feature subsets of Table 5, and compares these findings 
with those in Tsanas et al. (2010a) and Tsanas et al. (2010b). The generalization ability of the 
models is verified by the fact that the in-sample and out-of-sample errors were similarly low.  
 
Table 6: Summary of the Mean Absolute Error (MAE) results of this study, and 
comparison with the results of previous studies. 
Measures MAE for motor-UPDRS  MAE for total-UPDRS 
Selected feature subset for 
males in Table 5  1.62 ± 0.17 1.96 ± 0.23 
Selected feature subset for 
females in Table 5 1.72 ± 0.16 2.20 ± 0.21 
Selected feature subset in 
Tsanas et al. (2010a) 5.95 ± 0.19 7.52 ± 0.25 
Selected feature subset in 
Tsanas et al. (2010b) 6.57 ± 0.16 8.38 ± 0.23 
The reported MAE results were obtained with the Random Forests (RF) working in classification mode. The errors are 
reported in the form mean ± standard deviation. In Tsanas et al. (2010a) and Tsanas et al. (2010b) we had pooled together all 
the available phonations (no separation between male and female groups). The inter-rater variability (difference in clinical 
symptom assessment between trained clinicians) is about 4-5 UPDRS points (Post et al. 2005) and the results in this study 
demonstrate, for the first time, that a machine learning approach can do better than this benchmark. 
 
 We use the Wilcoxon rank sum test to demonstrate the significance of these findings by 
comparing the UPDRS results obtained using the methodology of this study against some 
benchmarks. We compared the distribution of the MAE for motor-UPDRS and total-UPDRS 
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against the MAE that are obtained using the mean motor-UPDRS and mean total-UPDRS 
(which are used as benchmarks, respectively) for males and for females. The null hypothesis 
is that the medians of the distributions are equal. The Wilcoxon rank sum test rejected the 
null hypothesis and the results are statistically significant (  0.001 for all four cases. In 
addition, we use as another benchmark the UPDRS value for each subject at baseline (that is, 
the UPDRS estimate is assumed constant for each subject at the baseline score), and compute 
the MAE distributions of motor-UPDRS and total-UPDRS by using this value. In this case, 
the null hypothesis is that the medians of the MAE distributions using the methodology of 
this study, and the MAE distributions using the baseline value for the individuals are equal. 
The Wilcoxon rank sum test rejected the null hypothesis and the results are statistically 
significant (  0.001 for all four cases. 
 With the exception of Tsanas et al. (2010a) and Tsanas et al. (2010b), we are not aware of 
any previous studies that have focused on replicating the average PD symptom severity when 
this is quantified by a clinical metric, such as the UPDRS. A recent study has attempted to 
replicate three aspects of the UPDRS metric (tremor, bradykinesia, and dyskinesia), using 
accelerometers (Patel et al. 2009). We refer to the Electronic Supplementary Material for 
details and a comparison of the results using the methodology of this study and Patel et al. 
(2009) in replicating the clinical evaluation (UPDRS assessment by the clinical rater) of those 
three elements. Not surprisingly, it appears that accelerometers are better suited compared to 
speech signals to replicate the clinicians’ assessment of average severity in those three motor 
symptoms. Although these three elements are important, they do not encompass the breadth 
of PD symptoms which are expressed in the diverse UPDRS metric, and therefore do not 
actually reflect the average PD symptom severity which we try to quantify in our work. 
 
4.3  Six month UPDRS tracking for the AHTD trial 
 
So far, we have focused on randomly selecting phonations and estimating the UPDRS 
without working on specific individuals for a period of time (UPDRS prediction). In this 
Section, we aim to test the model’s ability for UPDRS tracking (weekly UPDRS estimation 
of an individual for the six month duration of the trial using the speech recordings). One 
approach is to train the learner using the dysphonia measures computed from all subjects 
without including the dysphonia measures from the specific subject whose UPDRS we want 
to predict. However, this is a very unstable scheme due to the finiteness of the data (there are 
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only 42 subjects in the AHTD trial), and we elaborate further on this issue in the Discussion. 
For that reason, we have used the UPDRS tracking approach that we describe next. 
On every day the PWP took the AHTD tests, six sustained vowel phonations were 
recorded. Thus, as a proxy for leaving out all the dysphonia measures from a single subject 
for the 6-month duration of the AHTD trial (~140 speech signals × M dysphonia measures), 
we can leave out the dysphonia measures derived from one of the weekly tests, and test the 
learner’s out-of sample tracking ability using these dysphonia measures (~25 × M). However, 
we have noticed that our algorithms occasionally deliver quite large UPDRS differences 
using the out-of sample dysphonia measures derived from each of the six sustained vowel 
tests of individuals which were captured on the same day. This suggests that spurious 
artefacts pertaining to one or more of the six weekly recorded phonations may not be 
representative of the weekly UPDRS estimate of the patients. Therefore, we propose training 
the learner using the dysphonia measures from all the sustained vowel phonations of all 
patients, with the exception of the dysphonia measures derived from the first of each of the 
weekly phonations for a selected individual (about 20-25), which are used for testing. 
Subsequently, we repeat the same methodology training the system with all the dysphonia 
measures from all patients, excluding the dysphonia measures derived from the selected 
individual involving successively either the second, third, fourth, fifth or sixth sustained 
vowel phonation test. The six weekly out-of-sample MAE results are then averaged, resulting 
in a single UPDRS estimate. Our experiments suggest that the scheme with weighting the 
average UPDRS estimates from the dysphonia measures of the six weekly phonations is a 
more robust method compared to randomly selecting the dysphonia measures computed from 
one of the six weekly phonations.   
Figure 5 presents the UPDRS tracking of a male and a female PWP using the combination 
of the best feature subset and RF working in classification mode. We have purposefully 
chosen male and female PWP with uncharacteristic UPDRS patterns (whereas the norm for 
PWP is progressive increase in symptom severity) to demonstrate that the proposed methods 
can follow larger, unexpected UPDRS changes. The actual UPDRS of the presented male 
PWP increased slightly in the 3-month visit and subsequently reduced on the 6-month visit, 
whereas the female PWP shown here is the subject with the most irregular UPDRS pattern in 
the AHTD trial (sharp UPDRS increase in the 3-month visit and subsequent sharp decrease in 
the 6-month visit). The female subject in figure 5b is the individual we have used previously 
(Tsanas et al. 2010a). Inspection of figure 5c, 5d and the tracking figure of Tsanas et al. 
(2010a) verifies the superiority of the approach developed in the current study in remotely  
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Figure 5 Motor-UPDRS and total-UPDRS tracking over the 6-month trial period for a male and a 
female subject with irregular UPDRS pattern. The ‘baseline’, ‘3-month’ and ‘6-month’ UPDRS 
scores are shown. The out-of-sample MAE and the standard deviation of MAE computed for the 
subjects presented in this figure are also quoted. The computation of the out-of-sample MAE and the 
confidence intervals reported in this figure were estimated from the average MAE of the six weekly 
error estimates throughout the six month duration of the trial for the specific individual. 
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following UPDRS symptom severity when this is expressed in UPDRS terms. We remark 
that the proposed models replicate quite accurately the linearly interpolated motor-UPDRS 
and total-UPDRS scores in figure 5. Generally, UPDRS increases monotonically for most of 
the patients, and the algorithm’s tracking is even more precise in those cases. 
 
 
5. Discussion 
 
We have investigated the potential for using speech signals to estimate average PD 
progression with the standard reference clinical score, UPDRS. We stress that this study 
focused on PD telemonitoring and not PD diagnosis, which is a more difficult and subtle 
problem (to qualify as a diagnostic tool the methodology of this study should be applied in 
datasets that include healthy controls and, in addition, subjects with various neurological 
disorders that typically present PD-like symptoms). A wide range of known and novel speech 
signal processing algorithms (collectively known as dysphonia measures) have been 
implemented in order to uncover potentially concealed patterns in the PWP’s voice and 
establish a functional mapping of these patterns to UPDRS. We have experimented with 
feature selection algorithms, aiming to select a parsimonious model with good prediction 
accuracy. The out of sample MAE were 1.6 points for males and 1.7 points for females for 
the motor UPDRS (which spans the range 0-108), and 2.0 points for males and 2.2 points for 
females for the total UPDRS (which spans the range 0-176), suggesting that the proposed 
methodology can accurately replicate the linearly interpolated UPDRS scores based on 
clinicians’ subjective ratings. The new MAE results drastically improve upon Tsanas et al. 
(2010a) and Tsanas et al. (2010b) where the UPDRS was estimated to within 7.5 points. The 
improvement in the UPDRS estimation of this study is attributed to two factors: a) more 
sophisticated speech signal processing algorithms which uncover novel PD dysphonia 
patterns, b) the use of random forests, which clearly outperform CART in this application. 
We address each of these points later. We stress that we can replicate the clinicians’ UPDRS 
estimates with accuracy that is considerably greater than the inter-rater variability (4-5 
UPDRS points) (Post et al. 2005), a benchmark clinicians might want to refer to. These 
promising new results could convince more clinicians about the practical effectiveness of the 
proposed approach, and consequently lead to the adoption of the AHTD in larger clinical 
trials. 
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We started the exploration of the data by combining the two UPDRS sections with explicit 
“Speech” headings to form a composite speech-UPDRS score, and reported the association 
strength of speech-UPDRS with motor- and total-UPDRS. These results are built upon the 
idea that slight changes in the voice reflect some change in PD symptom severity. It is also 
highly likely that speech changes occur due to natural biological variation since humans do 
not produce identical outputs under identical conditions. Such sources of intrinsic variation in 
voice are, however, irrelevant to the systematic component of the relationship between voice 
and PD symptom severity: as we have demonstrated in this study and others, such intrinsic 
biological variability does not preclude prediction of PD symptom severity. It would however 
be of interest to understand such intrinsic biological variability of the voice for other 
purposes. The results of this study provide good statistical evidence that speech impairment 
and average, overall PD symptom severity are inherently linked, and intuitively justify the 
premise that UPDRS can be predicted by analysing speech signals alone.  
Previous studies had only computed some of the commonly used dysphonia measures to 
investigate the potential of using sustained vowels to track average PD symptom progression. 
In this study, we have significantly reinforced earlier findings using additional speech signal 
processing algorithms, and proposing a number of novel algorithms which are able to detect 
previously hidden patterns in PWP’s speech degradation. The new measures rely mainly in 
the physiological understanding that pathological voices exhibit increased tremor and high-
frequency noise, and attempt to quantify these characteristics using energy and entropy 
concepts. The fact that the feature selection algorithms showed heavy bias towards selecting 
the non-classical measures is compelling evidence that these new measures quantify 
clinically useful information in PD voices which may not be captured by the classical 
dysphonia measures. We elaborate further on the issue of dysphonia measures in PD in the 
discussion Section of the Electronic Supplementary Material. 
Interestingly, our experiments demonstrate that there are substantially different PD effects 
in the voices of male and female PWP. The mutual information and correlation coefficients for 
males in Table 3 and females in Table 4 reveal some interesting, and slightly surprising attributes. 
In particular, measures directly extracted from the fundamental frequency (both the standard 
deviation of the estimated  and the absolute difference to the population average  for 
matched healthy controls) appear strongly associated with UPDRS in females but apparently 
there is no similar distinctive pattern for males. We had previously reported that PPE, a measure 
which relies on the log-transform of the fundamental frequency, is one of the most important 
measures for predicting UPDRS (Tsanas et al. 2010). In fact, we have now established that this is 
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because PPE is an excellent predictor for UPDRS tracking in females, but is quite ineffective in 
males. Ultimately, the gender differentiation supports a tentative physiological conclusion: 
that the underlying processes of degradation in PD speech may be different in men and 
women. Moreover, the association strength of the dysphonia measures with UPDRS is much 
larger in females (Tables 3 and 4). In brief, we speculate this is because there is a distinct 
signature (pattern) characterising voice pathologies in females, whereas this pattern is masked 
in males due to the physiology of natural male voice production. Since higher fundamental 
frequencies tend to have lower perturbations (Baken and Orlikoff 2000), and given that 
women have higher average  (Titze 2000), it is plausible that even slight distortions in vocal 
performance (for example aperiodic ) reflect voice pathology in females with high 
probability, whilst similar distortions in males’ vocal performance can be attributed (at least 
partly) to normal vibrato. Thus, voice degradation quantified using some of the dysphonia 
measures (particularly those related to  could represent general symptom degradation in 
females, whereas similar quantification of the voice perturbations in males could be part of 
the variability in normal voice production mechanisms.  
We have experimented with nonlinear, nonparametric learners: CART and RF. We have 
used CART and RF working in both regression and classification modes, since the problem 
tackled in this study is amenable to both interpretations. In all simulations, RF outperformed 
CART, typically in excess of 1 UPDRS point. Our study agrees with Breiman’s findings 
(Breiman 2001) that RF perform better in classification mode. The reported MAE estimates 
come from the 100 runs 10-fold cross-validation scheme and reflect our best estimate of the 
asymptotic out-of-sample prediction error given the available data. As we have argued 
previously (Tsanas et al. 2010a), the reliability of the cross-validation implicitly assumes 
independence between samples, which may be violated since we have typically about 140 
samples from each of the 42 patients, and approximately 6,000 samples overall. However, 
any patient-specific validation scheme is unstable because there is not enough hold-out data 
to form reliable estimates of the learners’ performance. This was verified in our experiments 
with a leave-one-patient-out cross validation scheme, where the standard deviations around 
the computed MAE were almost as large as the error. A simple test that goes some way 
towards determining whether the samples are truly independent is to use as an additional 
input feature (along with the selected subset of the dysphonia measures) the patient index: if 
there is large dependency between samples from the same patient, the out-of-sample MAE of 
the learners will be noticeably reduced. In doing this simple experiment we noticed a 
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marginal MAE reduction of about 0.2 UPDRS points, which is statistically insignificant. This 
evidence supports the interpretation that there is no strong dependence between samples from 
each patient.  
Telemonitoring in healthcare is fast emerging, and is particularly important for PWP 
because it is often extremely awkward for those patients to make frequent visits to the clinic. 
Our findings could be useful in clinical trials, offering a novel approach to tracking average 
PD symptom severity by UPDRS remotely, and at frequent intervals. We envisage this 
technology finding application in future clinical trials of novel treatments which will require 
high-frequency, remote, and very large study populations. 
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